The discounted acquisition of a once-promising biotech development site signals just how far Emeryville's life sciences market has cratered. A San Francisco real estate investor has scooped up a 128,000-square-foot Emeryville property at roughly half its previous sale price, in a transaction that crystallizes the collapse of the East Bay life sciences market that, just […]
Thank you for your interest in The Registry. If you'd like to read further, you must Subscribe or Log In below to read the rest of this content.
Signup for news and special announcements!
You have successfully joined our subscriber list.
Seattle-based Tourbineau Real Estate Partners has paid $4 million for a half-acre...
ByThe RegistryNovember 13, 2026Alden Global Capital President Heath Freeman has agreed to acquire the San...
ByThe RegistryNovember 13, 2026OpenAI has signed a 70,000-square-foot direct lease at Peninsula Land & Capital's...
ByThe RegistryNovember 13, 2026Morgan Stanley's Prime Property Fund is marketing 150 California Street, a 249,960-square-foot,...
ByThe RegistryNovember 13, 2026